NCT00690079 - Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Chronic Pain

Interventions

DRUG

AZD1386

Oral admin. of doses at 11 days through a 12 days period. Cmax = 16 mikromol/L and AUCmax = 98 mikromol\*h/L

DRUG

Placebo

Oral admin. of doses at 11 days through a 12 days period.

Trial Locations (1)

Research Site, Macclesfield